Literature DB >> 22745333

Selective modulation of hepatic cytochrome P450 and flavin monooxygenase 3 expression during citrobacter rodentium infection in severe combined immune-deficient mice.

Beatrice A Nyagode1, William J Watkins, Ryan D Kinloch, Edward T Morgan.   

Abstract

The profile of selective modulation of hepatic cytochrome P450 (P450) gene expression caused by infection with the murine intestinal pathogen Citrobacter rodentium has been well characterized in multiple genetic backgrounds; yet, the mechanisms underlying this modulation are still not entirely understood. Although several studies have addressed the roles of cytokines from the innate immune system, the influence of the adaptive immune system is not known. To address this deficiency, we used mice harboring the severe combined immune deficiency (SCID) spontaneous mutation, which lack mature T and B lymphocytes and are unable to mount an acquired immune response. Female C57BL/6 (B6) and SCID mice were infected orally with C. rodentium and assessed for bacterial colonization/translocation and P450 and flavin monooxygenase-3 (Fmo3) expression levels after 7 days. SCID mice showed similar patterns of colonic bacterial colonization and a similar degree of colonic mucosal hypertrophy compared with infected B6 mice, but SCID mice displayed 6-fold greater bacterial translocation to the liver. In the SCID mice, Cyp4a10 and Cyp2b9 down-regulations were partially and fully blocked, respectively, whereas the regulation of other P450s and Fmo3 was similar in both strains. In the C3H genetic background, the SCID mutation also blocked the down-regulation of Cyp3a11, Cyp3a25, Cyp2d22, and Cyp2c29. The results clearly dissociate bacterial translocation to the liver from hepatic drug-metabolizing enzyme regulation and suggest a possible role of T cells, T-cell cytokines, or other proteins regulated by such cytokines in the selective regulation of a limited subset of hepatic P450 enzymes during C. rodentium infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22745333      PMCID: PMC3463824          DOI: 10.1124/dmd.112.046557

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  24 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure.

Authors:  Reginald F Frye; Virginia M Schneider; Carole S Frye; Arthur M Feldman
Journal:  J Card Fail       Date:  2002-10       Impact factor: 5.712

3.  Selective role for tumor necrosis factor-α, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen.

Authors:  Ryan D Kinloch; Choon-Myung Lee; Nico van Rooijen; Edward T Morgan
Journal:  Biochem Pharmacol       Date:  2011-05-06       Impact factor: 5.858

4.  Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract.

Authors:  R M Housley; C F Morris; W Boyle; B Ring; R Biltz; J E Tarpley; S L Aukerman; P L Devine; R H Whitehead; G F Pierce
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

5.  Keratinocyte growth factor as a mitogen for primary culture of rat hepatocytes.

Authors:  T Itoh; M Suzuki; Y Mitsui
Journal:  Biochem Biophys Res Commun       Date:  1993-05-14       Impact factor: 3.575

6.  Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium.

Authors:  Cameron P Simmons; Simon Clare; Marjan Ghaem-Maghami; Tania K Uren; Joanna Rankin; Allan Huett; Rob Goldin; David J Lewis; Thomas T MacDonald; Richard A Strugnell; Gad Frankel; Gordon Dougan
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

7.  Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium.

Authors:  Bruce A Vallance; Wanyin Deng; Kevan Jacobson; B Brett Finlay
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

Review 8.  Initiation and resolution of mucosal inflammation.

Authors:  Melanie A Sherman; Daniel Kalman
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

9.  Altered theophylline pharmacokinetics during acute respiratory viral illness.

Authors:  K C Chang; T D Bell; B A Lauer; H Chai
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

10.  Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response.

Authors:  L P Rivory; K A Slaviero; S J Clarke
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

View more
  1 in total

1.  Hepatic cytochrome P450s, phase II enzymes and nuclear receptors are downregulated in a Th2 environment during Schistosoma mansoni infection.

Authors:  Sylvie M Mimche; Beatrice A Nyagode; Matthew D Merrell; Choon-Myung Lee; Nina S Prasanphanich; Richard D Cummings; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2013-10-25       Impact factor: 3.922

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.